Update Venture DNA and Determine Next Actions
The founder uploads the finalised Health / MedTech Market Access asset to the central data room and updates core venture DNA records. They then evaluate the findings to select the next immediate task, whether progressing, re-testing, or escalating to specialist advisors. This maintains continuous momentum across the venture-building programme.
Finalising data room assets and updating venture DNA creates a transparent, immutable record of progress for stakeholders. It establishes explicit continuity by routing the venture into the correct subsequent stage based on evidence.
An updated digital data room containing the version-controlled asset, alongside updated venture DNA logs reflecting key market access decisions. A formally selected next task logged in the management platform with documented rationale.
Five questions an expert would ask when reviewing your output
Use these to challenge assumptions, pressure-test your logic, and check the quality of this action's output in the context of the parent task and wider venture development.
- 1
How does this newly uploaded market access asset alter your overall venture valuation and risk profile?
- 2
What specific updates have you made to your venture DNA to reflect the real costs of institutional adoption?
- 3
Why is your recommended next task the logical follow-on given the evidence strength established here?
- 4
How will you ensure that future team members or advisors utilise this data room asset effectively?
- 5
Under what conditions would the findings in this data room asset force a complete pivot of your go-to-market strategy?